Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Elstein

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Journal of Parkinson'S Disease|September 26, 2015
Color Discrimination in Patients with Gaucher Disease and Parkinson DiseaseShlomi Simon-Tov, Tama Dinur, Nir Giladi, et al.
British Journal of Haematology|March 16, 2011
Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleedingGalia Spectre, Batia Roth, Galia Ronen, et al.
Blood Cells, Molecules & Diseases|November 15, 2016
Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trialsAri Zimran, Deborah Elstein, Derlis E Gonzalez, et al.
Blood Cells, Molecules & Diseases|September 16, 2003
The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlationAriel Brautbar, Deborah Elstein, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|December 26, 2012
Phenotype in patients with Gaucher disease and Parkinson diseaseEli Ben Chetrit, Roy N Alcalay, Bettina Steiner-Birmanns, et al.
Blood Cells, Molecules & Diseases|December 3, 2014
Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher diseaseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.
British Journal of Haematology|March 4, 2006
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher diseaseItai Magal, Ehud Lebel, Gheona Altarescu, et al.
Blood Cells, Molecules & Diseases|November 4, 2011
Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early Access Program results from JerusalemDeborah Elstein, Gheona Altarescu, Hannah Maayan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2005
A comprehensive assessment of renal function in patients with Gaucher diseaseRachel Becker-Cohen, Deborah Elstein, Ayala Abrahamov, et al.
Journal of Thrombosis and Thrombolysis|April 14, 2016
The association between ABO blood group and obstetric hemorrhageLior Drukker, Naama Srebnik, Deborah Elstein, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Journal of Parkinson'S Disease|September 26, 2015
Color Discrimination in Patients with Gaucher Disease and Parkinson DiseaseShlomi Simon-Tov, Tama Dinur, Nir Giladi, et al.
British Journal of Haematology|March 16, 2011
Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleedingGalia Spectre, Batia Roth, Galia Ronen, et al.
Blood Cells, Molecules & Diseases|November 15, 2016
Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trialsAri Zimran, Deborah Elstein, Derlis E Gonzalez, et al.
Blood Cells, Molecules & Diseases|September 16, 2003
The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlationAriel Brautbar, Deborah Elstein, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|December 26, 2012
Phenotype in patients with Gaucher disease and Parkinson diseaseEli Ben Chetrit, Roy N Alcalay, Bettina Steiner-Birmanns, et al.
Blood Cells, Molecules & Diseases|December 3, 2014
Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher diseaseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.
British Journal of Haematology|March 4, 2006
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher diseaseItai Magal, Ehud Lebel, Gheona Altarescu, et al.
Blood Cells, Molecules & Diseases|November 4, 2011
Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early Access Program results from JerusalemDeborah Elstein, Gheona Altarescu, Hannah Maayan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2005
A comprehensive assessment of renal function in patients with Gaucher diseaseRachel Becker-Cohen, Deborah Elstein, Ayala Abrahamov, et al.
Journal of Thrombosis and Thrombolysis|April 14, 2016
The association between ABO blood group and obstetric hemorrhageLior Drukker, Naama Srebnik, Deborah Elstein, et al.
Pageof 16